NASDAQ: PBM
Psyence Biomedical Ltd Stock Ownership - Who owns Psyence Biomedical?

Insider buying vs selling

Have Psyence Biomedical Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PBM insiders and whales buy or sell their stock.

PBM Shareholders

What type of owners hold Psyence Biomedical Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Marc Gregory Balkin2,488.92%7,455,000$17.89MInsider
Newcourt Spac Sponsor LLC307.15%920,000$2.21MInsider
Polar Asset Management Partners Inc176.95%530,000$1.27MInsider
Parallel Advisors LLC50.50%151,250$363.00kInstitution
Virtu Financial LLC12.37%37,042$88.90kInstitution
Goldman Sachs Group Inc1.25%3,749$9.00kInsider
Bank Of America Corp1.12%3,346$8.03kInstitution
Ubs Group Ag0.34%1,007$2.42kInstitution
Stonehage Fleming Financial Services Holdings Ltd0.19%561$1.35kInstitution

1 of 1

PBM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PBM2.12%97.88%
CDT0.05%99.95%Net BuyingNet Buying
CMND0.44%0.00%
NCEL0.00%100.00%
VRAX0.53%4.40%

Psyence Biomedical Stock Ownership FAQ

Who owns Psyence Biomedical?

Psyence Biomedical (NASDAQ: PBM) is owned by 64.50% institutional shareholders, 2,974.26% Psyence Biomedical insiders, and 0.00% retail investors. Marc Gregory Balkin is the largest individual Psyence Biomedical shareholder, owning 7.46M shares representing 2,488.92% of the company. Marc Gregory Balkin's Psyence Biomedical shares are currently valued at $18.12M.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.